We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Compass Minerals
CMP
$1B
| $3.88M | 0.01% |
79,681
+15,164
| +24% | +$703K |
|
777
Enanta Pharmaceuticals
ENTA
$370M
| $3.87M | 0.01% |
77,104
+51,733
| +204% | +$2.68M |
|
778
Chord Energy
CHRD
$8.04B
| $3.86M | 0.01% |
5,151,309
+17,214
| +0.3% | +$11.1K |
|
|
CERN
779
DELISTED
Cerner Corp
CERN
| $3.86M | 0.01% |
56,324
-70,682
| -56% | -$4.86M |
|
|
HSII
780
DELISTED
Heidrick & Struggles
HSII
| $3.85M | 0.01% |
177,897
-85,345
| -32% | -$1.88M |
|
|
YMAB
781
DELISTED
Y-mAbs Therapeutics
YMAB
| $3.84M | 0.01% |
+88,808
| New | +$3.36M |
|
782
World Acceptance Corp
WRLD
$865M
| $3.83M | 0.01% |
58,532
+58,503
| +201,734% | +$3.66M |
|
783
QuidelOrtho
QDEL
$739M
| $3.83M | 0.01% |
17,133
-27,802
| -62% | -$4.36M |
|
|
MSGN
784
DELISTED
MSG Networks Inc.
MSGN
| $3.81M | 0.01% |
383,077
+71
| +0% | +$811 |
|
|
BBT
785
Beacon Financial Corp
BBT
$2.61B
| $3.8M | 0.01% |
344,832
+201,204
| +140% | +$2.59M |
|
786
First Horizon
FHN
$11.3B
| $3.8M | 0.01% |
381,133
-205,273
| -35% | -$1.87M |
|
787
Hanover Insurance
THG
$8.07B
| $3.79M | 0.01% |
37,391
+14,593
| +64% | +$1.43M |
|
788
Take-Two Interactive
TTWO
$39.6B
| $3.79M | 0.01% |
27,127
-3,242
| -11% | -$424K |
|
789
Semtech
SMTC
$15.6B
| $3.78M | 0.01% |
72,432
-79,440
| -52% | -$3.72M |
|
790
Akamai
AKAM
$15B
| $3.76M | 0.01% |
35,112
-43,359
| -55% | -$4.36M |
|
791
SiteOne Landscape Supply
SITE
$3.86B
| $3.75M | 0.01% |
32,861
+1,713
| +5% | +$159K |
|
792
US Physical Therapy
USPH
$1.24B
| $3.74M | 0.01% |
46,116
+37,357
| +426% | +$2.72M |
|
793
Graphic Packaging
GPK
$2.86B
| $3.72M | 0.01% |
266,053
+58,521
| +28% | +$787K |
|
|
KLDO
794
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $3.71M | 0.01% |
+500,000
| New | +$3.35M |
|
795
Akebia Therapeutics
AKBA
$254M
| $3.71M | 0.01% |
+272,959
| New | +$2.82M |
|
|
DHR.PRA
796
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $3.68M | 0.01% |
2,950
-2,050
| -41% | -$2.42M |
|
797
Lennox International
LII
$12.5B
| $3.67M | 0.01% |
15,757
-10,426
| -40% | -$2.11M |
|
798
Macy's
M
$5.7B
| $3.65M | 0.01% |
530,066
+372,819
| +237% | +$2.3M |
|
799
Laureate Education
LAUR
$4.99B
| $3.61M | 0.01% |
362,535
+360,948
| +22,744% | +$3.49M |
|
800
LyondellBasell Industries
LYB
$21B
| $3.61M | 0.01% |
54,964
-13,666
| -20% | -$813K |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.